Why Did the FDA Refuse to Add TECOS Data to Sitagliptin Label? Why Did the FDA Refuse to Add TECOS Data to Sitagliptin Label?

Although it ' s not clear exactly what Merck was requesting when it asked the FDA to add the TECOS data to the label for its type 2 diabetes drug, the recent refusal of the agency to do so is mystifying.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news